Proteome Sciences (PRM) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Dec 2024 07:08 AM
RNS
Loan Facility, Trading Update & Directorate Change
13 Sep 2024 07:00 AM
RNS
Interim Results and Directorate Change
16 May 2024 01:10 PM
RNS
Result of AGM
16 May 2024 07:00 AM
RNS
AGM Statement
26 Apr 2024 07:00 AM
RNS
Contract Win
10 Apr 2024 07:00 AM
RNS
Final Results
02 Jan 2024 07:00 AM
RNS
Completion of new facility in San Diego
30 Nov 2023 07:00 AM
RNS
Trading Update
02 Oct 2023 07:00 AM
RNS
Launch of Single Cell Proteomics Services
30 Aug 2023 02:14 PM
RNS
Investor Presentation
25 Aug 2023 07:00 AM
RNS
Interim Results
01 Jun 2023 09:43 AM
RNS
Repayment of Loan
17 May 2023 01:05 PM
RNS
Result of AGM
17 May 2023 07:00 AM
RNS
AGM Statement
12 May 2023 07:00 AM
RNS
Expansion into the US
14 Apr 2023 10:45 AM
RNS
Director/PDMR Shareholding
06 Apr 2023 11:34 AM
RNS
Director/PDMR Shareholding
06 Apr 2023 10:30 AM
RNS
Investor Presentation
04 Apr 2023 07:00 AM
RNS
Final Results
29 Mar 2023 07:00 AM
RNS
Notice of Results
06 Mar 2023 04:35 PM
RNS
Price Monitoring Extension
20 Feb 2023 07:00 AM
RNS
Trading Update
05 Jan 2023 07:00 AM
RNS
Milestone Payment for TMT®/TMTproT Sales
01 Dec 2022 04:38 PM
RNS
Grant of Options and PDMR/director shareholdings
12 Oct 2022 07:00 AM
RNS
Grant of Options and PDMR/director shareholdings
04 Oct 2022 07:00 AM
RNS
Change of Auditor
20 Sep 2022 04:40 PM
RNS
Second Price Monitoring Extn
20 Sep 2022 04:35 PM
RNS
Price Monitoring Extension
18 Aug 2022 07:00 AM
RNS
Appointment of Chief Financial Officer
11 Aug 2022 07:00 AM
RNS
Investor Presentation
04 Aug 2022 07:00 AM
RNS
Interim Results
03 Aug 2022 07:00 AM
RNS
Milestone towards Single Cell Proteomics services
26 May 2022 09:04 AM
RNS
Change of Registered Office
16 May 2022 01:24 PM
RNS
Result of AGM
16 May 2022 07:00 AM
RNS
AGM Statement
12 May 2022 07:00 AM
RNS
Substantial Contract Win
26 Apr 2022 04:45 PM
RNS
Director/PDMR Shareholding
21 Apr 2022 05:13 PM
RNS
Director/PDMR Shareholding
11 Apr 2022 07:00 AM
RNS
Investor Presentation
01 Apr 2022 06:01 PM
RNS
Director shareholding
31 Mar 2022 07:09 AM
RNS
Final Results
30 Mar 2022 11:24 AM
RNS
Loan amendment
29 Mar 2022 07:00 AM
RNS
Notice of Results
16 Feb 2022 04:40 PM
RNS
Second Price Monitoring Extn
16 Feb 2022 04:35 PM
RNS
Price Monitoring Extension
03 Feb 2022 07:00 AM
RNS
Trading Update
31 Dec 2021 12:36 PM
RNS
Price Monitoring Extension
20 Dec 2021 07:00 AM
RNS
Substantial Contract Win
09 Dec 2021 04:41 PM
RNS
Second Price Monitoring Extn
09 Dec 2021 04:36 PM
RNS
Price Monitoring Extension

Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for prognostic and therapeutic applications.

It listed on AIM in 1996 under the ticker PRM.

UK 100

Latest directors dealings